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Themolecular epidemiology andmechanisms of resistance of carbapenem-resistant Enterobacteriaceae (CRE) were determined
in hospitals in the countries of the Gulf Cooperation Council (GCC), namely, Saudi Arabia, United Arab Emirates, Oman, Qatar,
Bahrain, and Kuwait. Isolates were subjected to PCR-based detection of antibiotic-resistant genes and repetitive sequence-based
PCR (rep-PCR) assessments of clonality. Sixty-two isolates which screened positive for potential carbapenemase production
were assessed, and 45 were found to produce carbapenemase. The most common carbapenemases were of the OXA-48 (35 iso-
lates) and NDM (16 isolates) types; 6 isolates were found to coproduce the OXA-48 and NDM types. No KPC-type, VIM-type, or
IMP-type producers were detected. Multiple clones were detected with seven clusters of clonally related Klebsiella pneumoniae.
Awareness of CRE in GCC countries has important implications for controlling the spread of CRE in theMiddle East and in hos-
pitals accommodating patients transferred from the region.
International travel is a major mode of the spread of multiresis-tant Gram-negative bacilli, including carbapenem-resistant
Enterobacteriaceae (CRE) (1). The countries of the Gulf Coopera-
tion Council (GCC) (Saudi Arabia, United Arab Emirates [UAE],
Oman, Kuwait, Qatar, and Bahrain) exemplify the potential for
international travel as a significant issue: large numbers of citizens
seek medical care in specialized centers in the United States and
Europe, substantial proportions of the population are migrant
workers from the Indian subcontinent, and millions visit the re-
gion annually for theHajj and other religious events (2). As one of
many desperately needed first steps to control the spread of CRE,
we aimed to determine in this collaborative work the molecular
genetics of CRE in the countries of the GCC. To our knowledge
there has been no surveillance on themolecular genetics of CRE in
this region in the past. For this reason,we have performed a “snap-
shot” assessment of the molecular epidemiology of CRE in the
countries of the Gulf Cooperation Council.
MATERIALS AND METHODS
Bacterial isolates. Between July 2011 and January 2013, 413 clinical Esch-
erichia coli andKlebsiella pneumoniae isolates were collected from six par-
ticipating institutes across the GCC states (one hospital each from Saudi
Arabia, United Arab Emirates [UAE], Kuwait, Qatar, Oman, and Bah-
rain) (Table 1), as part of a region-wide collaborative study onmultidrug-
resistant Gram-negative bacilli. E. coli and Klebsiella spp. were identified
and tested for their susceptibility to a panel of antimicrobials using semi-
automated systems in each clinical microbiology laboratory (Table 1).
Isolates were included on the basis of showing decreased susceptibility to
cefotaxime (MIC,2 g/ml), ceftriaxone (MIC,2 g/ml), ceftazidime
(MIC, 8 g/ml), cefepime (MIC, 16 g/ml), imipenem (MIC, 2
g/ml), or meropenem (MIC, 2 g/ml). Only one isolate per patient
was included.
Isolates were sent to the research laboratory at the University of
Queensland Centre for Clinical Research (UQCCR). Bacterial species
were confirmed by matrix-assisted laser desorption ionization–time of
flight mass spectrometry (MALDI-TOF MS) on a Microflex platform
(Bruker Daltonics, Inc.). All 413 isolates underwent initial screening for
carbapenem resistance as determined by reduced susceptibility to ertap-
enem by disk diffusion; ertapenem was chosen as the screening carbap-
enem based on its ability to detect NDM-1, KPC, and low-level carbap-
enemase producers (3).
PCR for carbapenemase genes andCTX-M-15ESBL.Crude genomic
DNA for PCR was extracted from the isolates using the heat lysis method.
The presence of genes of the blaNDM and blaOXA-48 types (4, 5) (Table 2)
was sought on all isolates with reduced susceptibility to ertapenem, using
a multiplex PCR with GoTaq green master mix. PCR was performed with
0.4 M each primer and 0.75 l of DNA template. The PCR conditions
were as follows: initial denaturation at 95°C for 2 min, followed by 35
cycles of denaturation at 95°C for 30 s, annealing at 55°C for 45 s, and
extension at 70°C for 60 s, and a final extension at 70°C for 5 min. PCR
Received 23 September 2013 Returned for modification 14 November 2013
Accepted 9 March 2014
Published ahead of print 17 March 2014
Address correspondence to Hosam M. Zowawi, h.zowawi@uq.edu.au.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
doi:10.1128/AAC.02050-13
June 2014 Volume 58 Number 6 Antimicrobial Agents and Chemotherapy p. 3085–3090 aac.asm.org 3085
 o
n
 N
ovem
ber 5, 2015 by University of Queensland Library
http://aac.asm
.org/
D
ow
nloaded from
 
products of the blaOXA-48-type gene found in 10 different K. pneumoniae
isolates representing different clones were sequenced to identify the
blaOXA-48-type variants. All isolates with a reduced susceptibility to ertap-
enem were also tested in a singleplex reaction for the other major carbap-
enemase groups that confer clinically relevant resistance to carbapenems,
the blaKPC, blaVIM, and blaIMP types (4–8) (Table 2). Isolates with negative
PCR results for the tested carbapenemase genes were subjected to the
Carba NP test, as described previously (9). PCR for blaCTX-M-15-type
genes was also performed on the isolates to check if they were coharboring
this pandemic extended-spectrum beta-lactamase (ESBL) type (10) (Ta-
ble 2).
Plasmid typing. Isolates found carrying genes of the blaOXA-48 type
were subjected to PCR-based replicon typing analysis (PBRT), as de-
scribed by Carattoli et al. (11), to determine plasmid incompatibility
types. The primer pairs targeting IncL/M were used, and isolates negative
for IncL/M were subsequently screened for IncA/C (Table 1). These two
plasmid replicon types were selected based on reports suggesting dissem-
ination of blaOXA-48 in IncL/M- and IncA/C-type plasmids (12, 13).
Clonal analysis of NDM- or/and OXA-48-producing Klebsiella
pneumoniae by rep-PCR. The genetic relatedness among K. pneumoniae
isolates from the GCC was determined by repetitive sequence-based PCR
(rep-PCR) typing using the DiversiLab system (bioMérieux, Oakleigh,
Australia). The DNA fragment patterns were analyzed by the appropriate
software using Pearson correlation coefficient pairwise pattern matching
to determine the clonal relationships and to create dendrograms. A cluster
of closely related isolates was defined as isolates sharing95% similarity
and indistinguishable isolates of97% (14).
Human ethics. The University of Queensland granted human ethics
clearance to conduct this project (no. 2011000474). Permission fromKing
AbdulazizMedical City, Saudi Arabia, was granted to conduct the region-
wide collaborative study on multidrug resistant Gram-negative bacilli
(reference no. IRBC/193/12).
RESULTS
Bacterial isolates and ertapenem susceptibility. Of the 413 iso-
lates assessed, a total of 62 nonrepetitive isolates that were not
susceptible to ertapenem were subjected to further analysis; 53
were K. pneumoniae, and 9 were E. coli (Table 1).
Antibiotic resistance genes.A total of 35 (49%) isolates (34K.
pneumoniae and 1 E. coli) were OXA-48-type producers and a
total of 16 (23%) (15K. pneumoniae and 1 E. coli) wereNDM-type
producers. Six of these isolates coproduced the NDM type with
the OXA-48 type, and all were K. pneumoniae isolates from Saudi
Arabia (Table 1). Sequencing results of the blaOXA-48-type gene
carried by representative K. pneumoniae isolates from each clone
showed that all were carrying blaOXA-48 except one isolate from
Qatar that produced OXA-181 (Fig. 1). All 62 isolates were nega-
tive for genes of the blaKPC, blaVIM, and blaIMP types. A total of 17
(27%) isolates (7 E. coli and 10 K. pneumoniae) were negative for
all the tested carbapenemase genes. These isolates were also nega-
tive for carbapenemase production, as shown by the Carba NP
test.
Genes of the blaCTX-M-15 type were detected in 7 (78%) E. coli
isolates and in 41 (77%)K. pneumoniae isolates. Among the E. coli
isolates, the blaCTX-M-15-type ESBL gene was coharbored with the
blaNDM-type gene in a single isolate. Coproduction of the CTX-
M-15 type in K. pneumoniae with NDM occurred in 13 isolates
and coproduction with the OXA-48 type in 23 isolates. Five K.
pneumoniae isolates carried all 3 (blaCTX-M-15-type, blaNDM-type,
and blaOXA-48) genes. Of all isolates that tested negative for car-
bapenemases (n 17), 94% produced CTX-M-15-type ESBL.
Plasmid replicon typing. Among the 35 OXA-48-type-pro-
ducing isolates, 23 (62%) were plasmid replicon type IncL/M, andT
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all were from Saudi Arabia. Of the IncL/M-negative isolates (n
14), 2 were positive for IncA/C.
Clonal analysis of carbapenem-resistant Klebsiella pneu-
moniae by rep-PCR. Clonal analysis was performed on all
carbapenemase-producing K. pneumoniae isolates from different
countries within the GCC. The rep-PCR results reveal seven well-
defined clusters (Fig. 1). The main cluster (cluster A) represented
six blaNDM-type- and blaOXA-48-carrying K. pneumoniae isolates
from Saudi Arabia. Two smaller clusters (cluster B and C), repre-
senting four NDM-type-positive isolates and five OXA-48-posi-
tive isolates, respectively, were also observed from Saudi Arabia.
Additional clusters of NDM-type-positive isolates from the UAE
(cluster D), and OXA-48-positive isolates from Saudi Arabia
(clusters E, F, and G), demonstrated high genetic relatedness
(97% similarity). NDM-type-producing isolates from Qatar
and Oman were genetically unrelated to all other NDM-type-
positive strains isolated from the region (Fig. 2). Analysis by the
DiversiLab system demonstrated good correlation between the
isolates and their country of origin. Figure 2 highlights the three
well-defined clusters (A and B from Saudi Arabia and C from
UAE) of NDM-type-producing K. pneumoniae and demonstrates
the high genetic relatedness of isolates from individual hospitals.
DISCUSSION
Wehave described themolecular genetics of recent isolates of CRE
from patients in selected GCC hospitals. We had several major
findings. First, we have found that the OXA-48-type carbapen-
emase was the dominant mechanism responsible for CRE in this
study, and it has been identified for the first time inK. pneumoniae
and E. coli isolates from Qatar. Genes of the OXA-48 type and
related OXA enzymes have been found to be widely prevalent in
North Africa, the Middle East, and the Indian subcontinent (15),
and,more importantly, large numbers of outbreaks have occurred
in regions such as Europe and Australia, where CRE is not en-
demic, as a result of international transfer of patients (12, 16). In
turn, this has resulted in endemicity in hospitals in countries such
as France (12). OXA-48 producers have recently been reported for
the first time in the United States (17). Importantly, the first re-
ported case in the United States was a patient who had been re-
cently hospitalized in Saudi Arabia (17). There is clearly a need to
consider colonization of OXA-48 producers in patients trans-
ferred from the Middle East to the United States or Europe for
medical care.
Second, we have found that multiple clones of OXA-48-type-
producing K. pneumoniae are circulating within hospitals in the
Gulf Cooperation Council (Fig. 1). This finding suggests that
OXA-48-type producers have been prevalent in hospitals in the
region for a prolonged period of time. The finding of isolates shar-
ing common rep-PCR profiles reemphasizes the need for opti-
mized infection control in hospitals in the region, especially given
the previous findings of clusters of multiresistant Acinetobacter
baumannii in hospitals in the region (18).
Third, we have detectedNDM-type producers in several coun-
tries across the GCC. Although there was a high diversity of rep-
PCR profiles in different isolates from different countries, com-
mon profiles were found within individual hospitals (Fig. 2).
NDM producers have been previously identified in countries of
the Gulf Cooperation Council (2, 19), and international transfer
of NDM-1 producers from patients previously hospitalized in the
Middle East has been reported (20). However, this is the first re-
port describing the identification of NDM-type-producing K.
pneumoniae in Qatar and isolates that are coharboringNDM-type
producers with OXA-48-type producers in Saudi Arabia. Index
patients in outbreaks of NDM-1 producers occurring in North
America and Europe have typically had previous hospitalizations
in overseas countries (21), emphasizing the need for preemptive
contact isolation precautions in patients with previous overseas
health care contacts (1).
No isolate was found to produce the KPC, VIM, or IMP beta-
lactamase, although these carbapenemases have been previously
detected in Saudi Arabia andKuwait (2, 22–24). For 17 isolates, no
carbapenemase activity or carbapenemase genes were identified,
suggesting a noncarbapenemase-related resistance mechanism.
These isolates produced genes of the CTX-M-15 type and most
likely had extended-spectrum beta-lactamase production associ-
ated with decreased permeability of the outer membrane (25).
In summary, we have evaluated CRE in hospitals from across
the Gulf Cooperation Council. Although this is not a formal sur-
veillance study, it is the first “snapshot” study to determine the
molecular epidemiology of CRE in the region. Our findings of
multiple clusters of OXA-48-type- and NDM-type-producing K.
pneumoniae have important implications for control of spread of
CRE both in the Middle East and in hospitals accommodating
patients transferred from the region. Additionally, attention to
hospital antibiotic stewardship, the availability of over-the-coun-
TABLE 2 Oligonucleotides used to amplify selected beta-lactamase genes
Primer name Target Sequence (5=¡ 3=) Size (bp)
Annealing
temp (°C) Reference
CTX-M-15-F blaCTX-M-15 CACACGTGGAATTTAGGGACT 996 55 10
CTX-M-15-R GCCGTCTAAGGCGATAAACA
IMP-F blaIMP CTACCGCAGCAGAGTCTTTGC 591 58 7
IMP-R GAACAACCAGTTTTGCCTTACC
KPC-F blaKPC ATCTGACAACAGGCATGACG 452 55 4
KPC-R GACGGCCAACACAATAGGTG
NDM-F blaNDM GCAGGTTGATCTCCTGCTTG 203 55 4
NDM-R ACGGTTTGGCGATCTGGT
OXA-48-F blaOXA-48 GCGTGGTTAAGGATGAACAC 438 55 5
OXA-48-R CATCAAGTTCAACCCAACCG
VIM-F blaVIM GATGGTGTTTGGTCGCATA 390 55 8
VIM-R CGAATGCGCAGCACCAG
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FIG 1 Dendrogram illustrating the genetic relationship and clusters of 43 NDM- or OXA-48-producing K. pneumoniae isolates from the GCC states. ND, not
determined; NT, not tested.
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ter antibiotics, and agricultural use of antibiotics all have relevance
to control of CRE in the region.
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